A study to assess the Incidence of multiple sclerosis relapses and pseudo-relapses following mRNA COVID-19 vaccination
Latest Information Update: 15 Dec 2021
At a glance
- Drugs Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
- 15 Dec 2021 New trial record